Common (1% to 10%): Pruritus, urticarial, face edemaUncommon (0.
1% to 1%): Erythema, rashRare (less than 0.
1%): Angioedema, diaphoresisFrequency not reported: Ecchymosis and tissue necrosis
Common (1% to 10%): Nausea, vomitingRare (0.
01% to 0.
1%): Diarrhea, dry mouth, tongue edemaVery rare (less than 0.
01%): Dysphagia
Common (1% to 10%): Anaphylactoid reactionsFrequency not reported: Dermal manifestations (urticaria with or without pruritus, erythema, maculopapular rash); dry mouth, sweating, conjunctival symptoms; facial, peripheral, and angioneurotic edema; symptoms related to the respiratory system include sneezing, nasal stuffiness, coughing, choking, dyspnea, chest tightness and wheezing, which may be initial manifestations of more severe and infrequent reactions including asthmatic attack, laryngospasm and bronchospasm with or without edema, pulmonary edema, apnea and cyanosis
Rarely, these allergic-type reactions can progress into anaphylaxis with loss of consciousness and coma and severe cardiovascular disturbances.
Common (1% to 10%): RhinitisUncommon (0.
1% to 1%): Coughing, dyspneaRare (0.
01% to 0.
1%): Larynx edemaVery rare (less than 0.
01%): Apnea, bronchospasm
Uncommon (0.
1% to 1%): HypotensionRare (0.
01% to 0.
1%): Thrombophlebitis, tachycardia, ventricular fibrillation, pallor, vasodilation, cyanosisVery rare (less than 0.
01%): Disseminated intravascular coagulation resulting in death; arrhythmia; bradycardia; cardiac arrest, circulatory failure; abnormal ECG; heart block; phlebitisFrequency not reported: Generalized vasodilation, flushing and venospasm; occasionally thrombosis; severe cardiovascular responses include rare cases of hypotensive shock, coronary insufficiency, cardiac arrhythmia, fibrillation and arrest; extravasation with burning pain; hematomas; vascular constriction due to injection rate; thrombosis
These severe reactions are usually reversible with prompt and appropriate management; however, fatalities have occurred.
Uncommon (0.
1% to 1%): Thyroid function tests indicative of hypothyroidism or transient thyroid suppression in adults and pediatric patients (including infants)
Uncommon (0.
1% to 1%): Periorbital edemaRare (0.
01% to 0.
1%): ConjunctivitisVery rare (less than 0.
01%): Vision disorders
Rare (less than 0.
1%): Injection side reaction
Rare (0.
01% to 0.
1%): Dizziness; paraesthesia; taste perversionVery rare (less than 0.
01%): Agitation, coma, convulsions, dyskinesia, paralysis, tremor, somnolenceFrequency not reported: Aphasia; syncope, paresis; paralysis resulting from spinal cord injury and pathology associated with syndrome of transverse myelitis; visual field losses which are usually transient but may be permanent; coma and death; headache, trembling, shaking, numbness
Very rare (less than 0.
01%): Urinary incontinence
Very rare (less than 0.
01%): Thirst
Very rare (less than 0.
01%): Involuntary muscle contractions, myalgia, leg painFrequency not reported: Spasm
Very common (10% or more): Hot flushes, painRare (0.
01% to 0.
1%): MalaiseVery rare (less than 0.
01%): Edema, abnormal cryingFrequency not reported: Chills without fever and lightheadedness
Very rare (less than 0.
01%): Anxiety
Very rare (less than 0.
01%): Acute renal failure, decrease in renal functionFrequency not reported: Temporary renal shutdown or other nephropathy
Frequency not reported: Red blood cell clumping and agglutination, crenation and interference in clot formation